INSP logo

Inspire Medical Systems Inc. (INSP)

$59.41

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on INSP

Market cap

$1.72B

EPS

3.35

P/E ratio

15.2

Price to sales

2.22

Dividend yield

--

Beta

0.670012

Price on INSP

Previous close

$59.12

Today's open

$58.58

Day's range

$57.80 - $59.49

52 week range

$38.91 - $147.03

Profile about INSP

CEO

Timothy P. Herbert

Employees

1333

Headquarters

Golden Valley, MN

Exchange

New York Stock Exchange

Shares outstanding

28966119

Issue type

Common Stock

INSP industries and sectors

Healthcare

Medical Equipment & Supplies

News on INSP

Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference

MINNEAPOLIS, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 38th Annual Healthcare Conference on Tuesday, December 1, 2026.

news source

GlobeNewsWire • 19 hours ago

news preview

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Inspire Medical's strong Inspire V adoption, improving reimbursement clarity and patient access initiatives support growth despite near-term headwinds.

news source

Zacks Investment Research • Nov 11, 2026

news preview

INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?

Inspire Medical shares have rallied 12.1% in three months, but reimbursement hurdles and weak revenues raise questions about whether the gains can continue.

news source

Zacks Investment Research • Nov 10, 2026

news preview

Inspire Medical Systems: The Moat Just Passed Its Worst-Case Stress Test

Inspire Medical Systems remains fundamentally strong despite severe reimbursement and coding disruptions, which the market has mispriced as permanent impairment. INSP's gross margin expanded to 86%, and operating cash flow reached $82.5M over nine months, even as revenue declined 7.9% year-over-year due to administrative headwinds. Management attributes nearly all revenue shortfall to coding issues, with growth expected to resume post-2027 as a permanent CPT code takes effect in January 2028.

news source

Seeking Alpha • Nov 4, 2026

news preview

These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results

Inspire Medical Systems, Inc. (NYSE:INSP) reported upbeat earnings for the third quarter on Monday.

news source

Benzinga • Nov 3, 2026

news preview

Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference

MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026. Inspire is scheduled to present at 2:40 p.m.

news source

GlobeNewsWire • Nov 3, 2026

news preview

Inspire Medical Systems Q3 Earnings Call Highlights

Inspire Medical Systems NYSE: INSP reported third-quarter revenue of $206.7 million, down 7.9% from a year earlier but up 3% sequentially, as stronger-than-expected U.S. performance offset weaker international results. The company said coding and reimbursement challenges continued to weigh on results, though management expressed growing confidence that the disruption is easing.

news source

MarketBeat • Nov 3, 2026

news preview

Inspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call Transcript

Inspire Medical Systems, Inc. ( INSP ) Q3 2026 Earnings Call November 2, 2026 5:00 PM EST Company Participants Timothy Herbert - Founder, Chairman, CEO & President Matthew Osberg - Executive VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Adam Maeder - Piper Sandler & Co., Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Anthony Petrone - Mizuho Securities USA LLC, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division Travis Steed - BofA Securities, Research Division Keith Hinton - Prime Executions, Inc., Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division Michael Sarcone - Jefferies LLC, Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Kratky - Leerink Partners LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Christopher Pasquale Presentation Operator Good afternoon.

news source

Seeking Alpha • Nov 3, 2026

news preview

Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results

MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2026.

news source

GlobeNewsWire • Nov 2, 2026

news preview

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings

The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 3, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Inspire Medical Systems Inc.

Open an M1 investment account to buy and sell Inspire Medical Systems Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in INSP on M1